The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma.

Saved in:
Bibliographic Details
Title: The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma.
Authors: Kuehn JC; Department of Medicine I, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany., Neidert NN; Department of Neurosurgery, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany., Zhang J; Department of Neurosurgery, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany., Mutter J; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Alig S; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Essen, Essen, Germany., Klingler C; Department of Medicine I, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany., Hummel F; Department of Medicine I, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany., Ranganathan L; Department of Medicine I, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany., Bleul S; Department of Medicine I, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany., Beck J; Department of Neurosurgery, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany., Prinz M; Institute of Neuropathology, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany.; BIOSS Centre for Biological Signalling Studies and Centre for Integrative Biological Signalling Studies (CIBSS), University of Freiburg, Freiburg, Germany., Diehn M; Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA., Alizadeh A; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Duyster J; Department of Medicine I, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK) partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany., Sankowski R; Institute of Neuropathology, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK) partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany., Heiland DH; Department of Neurosurgery, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK) partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.; Department of Neurological Surgery, Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Scherer F; Department of Medicine I, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany. florian.scherer@uniklinik-freiburg.de.; German Cancer Consortium (DKTK) partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany. florian.scherer@uniklinik-freiburg.de.
Source: Leukemia [Leukemia] 2025 Jun; Vol. 39 (6), pp. 1532-1535. Date of Electronic Publication: 2025 Apr 10.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-025-02600-y